Alternative funding: Disease foundations, govt sources promote available capital

Eager to help firms access capital while government funding is squeezed and venture capitalists are backing away from early-stage technology - and even Big Pharma are cutting research programs - alternative sources of capital are reaching out to the drug development industry.